Unknown

Dataset Information

0

Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathway.


ABSTRACT:

Background

Mesenchymal Stromal Cells (MSCs) remain poorly characterized because of the absence of manifest physical, phenotypic, and functional properties in cultured cell populations. Despite considerable research on MSCs and their clinical application, the biology of these cells is not fully clarified and data on signalling activation during mesenchymal differentiation and proliferation are controversial. The role of Wnt pathways is still debated, partly due to culture heterogeneity and methodological inconsistencies. Recently, we described a new bone marrow cell population isolated from MSC cultures that we named Mesodermal Progenitor Cells (MPCs) for their mesenchymal and endothelial differentiation potential. An optimized culture method allowed the isolation from human adult bone marrow of a highly pure population of MPCs (more than 97%), that showed the distinctive SSEA-4+CD105+CD90(neg) phenotype and not expressing MSCA-1 antigen. Under these selective culture conditions the percentage of MSCs (SSEA-4(neg)CD105+CD90(bright) and MSCA-1+), in the primary cultures, resulted lower than 2%.

Methodology/principal finding

We demonstrate that MPCs differentiate to MSCs through an SSEA-4+CD105+CD90(bright) early intermediate precursor. Differentiation paralleled the activation of Wnt5/Calmodulin signalling by autocrine/paracrine intense secretion of Wnt5a and Wnt5b (p<0.05 vs uncondictioned media), which was later silenced in late MSCs (SSEA-4(neg)). We found the inhibition of this pathway by calmidazolium chloride specifically blocked mesenchymal induction (ID???=? 0.5 µM, p<0.01), while endothelial differentiation was unaffected.

Conclusion

The present study describes two different putative progenitors (early and late MSCs) that, together with already described MPCs, could be co-isolated and expanded in different percentages depending on the culture conditions. These results suggest that some modifications to the widely accepted MSC nomenclature are required.

SUBMITTER: Fazzi R 

PROVIDER: S-EPMC3183072 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathway.

Fazzi Rita R   Pacini Simone S   Carnicelli Vittoria V   Trombi Luisa L   Montali Marina M   Lazzarini Edoardo E   Petrini Mario M  

PloS one 20110929 9


<h4>Background</h4>Mesenchymal Stromal Cells (MSCs) remain poorly characterized because of the absence of manifest physical, phenotypic, and functional properties in cultured cell populations. Despite considerable research on MSCs and their clinical application, the biology of these cells is not fully clarified and data on signalling activation during mesenchymal differentiation and proliferation are controversial. The role of Wnt pathways is still debated, partly due to culture heterogeneity an  ...[more]

Similar Datasets

| S-EPMC2809059 | biostudies-literature
| S-EPMC7212324 | biostudies-literature
| S-EPMC4377076 | biostudies-literature
| S-EPMC2922230 | biostudies-literature
| S-EPMC5395723 | biostudies-literature
| S-EPMC4990471 | biostudies-literature
| S-EPMC5312417 | biostudies-literature
| S-EPMC8910760 | biostudies-literature
| S-EPMC3837622 | biostudies-literature
| S-EPMC5322933 | biostudies-literature